NON-UROTHELIAL BLADDER

Clinical trials for NON-UROTHELIAL BLADDER explained in plain language.

Never miss a new study

Get alerted when new NON-UROTHELIAL BLADDER trials appear

Sign up with your email to follow new studies for NON-UROTHELIAL BLADDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for rare cancers: Two-Drug combo enters key trial

Disease control Ongoing

This study is testing whether a combination of two immunotherapy drugs, nivolumab and ipilimumab, can help control advanced, rare cancers of the urinary and reproductive systems. It is for adults whose cancer has spread and who have few other treatment options. The main goal is t…

Matched conditions: NON-UROTHELIAL BLADDER

Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

NON-UROTHELIAL BLADDER

Get alerted when new NON-UROTHELIAL BLADDER trials appear

New hope for rare cancers: Two-Drug combo enters key trial